Eucaine
| Clinical data | |
|---|---|
| Trade names | Beta-Eucaine |
| Other names |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H21NO2 |
| Molar mass | 247.338 g·mol−1 |
| 3D model (JSmol) | |
| |
Eucaine, also known as β-eucaine or Betacaine, is a drug that was previously used as a local anesthetic. It was designed as an analog of cocaine and was one of the first synthetic chemical compounds to find general use as an anesthetic. It is a white, crystalline solid. Prior to World War I, Britain imported eucaine from Germany. During the war, a team including Jocelyn Field Thorpe and Martha Annie Whiteley developed a synthesis in Britain.
The brand name Betacaine can sometimes refer to a preparation containing lidocaine, not eucaine.